Detalhe da pesquisa
1.
Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector Respiratory Syncytial Virus (RSV) Vaccine Encoding Prefusion F in Adults 18-50 Years and RSV-Seropositive Children 12-24 Months.
J Infect Dis
; 227(1): 71-82, 2022 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36259542
2.
Safety, tolerability, and immunogenicity of V114 pneumococcal vaccine compared with PCV13 in a 2+1 regimen in healthy infants: A phase III study (PNEU-PED-EU-2).
Vaccine
; 41(15): 2456-2465, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36841723
3.
Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study.
Hum Vaccin Immunother
; 18(1): 1-10, 2022 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34085900
4.
Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27-45â¯years of age compared to women 16-26â¯years of age: An open-label phase 3 study.
Vaccine
; 39(20): 2800-2809, 2021 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33676783
5.
Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D-Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media-A Double-Blind Randomized Clinical Trial in Finland.
J Pediatric Infect Dis Soc
; 5(3): 237-248, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27125273
6.
Safety and immunogenicity of an intramuscular quadrivalent influenza vaccine in children 3 to 8 y of age: A phase III randomized controlled study.
Hum Vaccin Immunother
; 12(12): 3072-3078, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27565435